Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
APYX
#3783
Apyx Medical Corporation Common Stock
3.8
4
USD
-1.03%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
-1.03%
Changement Mensuel
+4.92%
Evolution sur 6 mois
+10.98%
Changement Annuel
+258.88%
Clôture Précédente
3.8
8
Open
3.8
4
Bid
Ask
Low
3.8
4
High
3.8
4
Volume
8
Marchés
Actions des Marchés US
Soins de Santé
APYX
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
34.32 M
34.43 M
34.6 M
34.64 M
37.79 M
41.83 M
—
Valuation ratios
Enterprise value
205.31 M
410.81 M
77.21 M
87.5 M
66.81 M
154.26 M
404.04 M
Price to earnings ratio
—
-29.14
-3.76
-4.94
-2.39
-12.83
-25.9
Price to sales ratio
—
9.07
1.95
1.77
1.17
2.72
7.32
Price to cash flow ratio
—
-42.12
-4.29
-17.61
-3.11
-17.98
-40.43
Price to book ratio
—
8.2
2.31
3.46
3.95
9.89
15
Enterprise value to EBITDA ratio
-10.7
-30.33
-3.41
-2.55
-1.54
-19.85
-32.41
Profitability ratios
Return on assets %
-0.16
-0.22
-0.45
-0.24
-0.36
-0.17
-0.19
Return on equity %
-0.19
-0.28
-0.61
-0.7
-1.64
-0.76
-1.31
Return on invested capital %
-438.32
-355.8
-348.77
-218.37
-312.26
-113.41
-128.55
Gross margin %
63.17
69.26
65.45
64.49
61.04
62.53
249.4
Operating margin %
-72.47
-29.78
-52.94
-32.97
-39.18
-12.2
-61.39
EBITDA margin %
-69.27
-27.92
-50.94
-36.79
-37.93
-10.96
-56.34
Net margin %
-42.93
-31.27
-52.09
-35.75
-48.78
-21.22
-99.41
Liquidity ratios
Quick ratio
6.78
4.09
2.63
4.74
4.56
4.26
16.47
Current ratio
7.22
4.6
3.63
5.52
5.26
5
19.62
Inventory turnover
2.24
2.75
1.66
1.71
2.14
2.45
2.37
Asset turnover
0.35
0.68
0.74
0.8
0.67
0.8
0.87
Solvency ratios
Debt to assets ratio
—
—
—
0.48
0.6
0.59
2.57
Debt to equity ratio
—
—
—
1.44
2.72
2.7
18.33
Long term debt to total assets ratio
—
—
—
0.42
0.52
0.52
2.28
Long term debt to total equity ratio
—
—
—
1.24
2.39
2.4
16.3
Per share metrics
Operating cash flow per share
—
-0.3
-0.59
-0.15
-0.51
-0.19
-0.2
EBIT per share
—
-0.42
-0.68
-0.58
-0.53
-0.16
-0.16
EBITDA per share
—
-0.39
-0.66
-0.56
-0.51
-0.14
-0.14
Total debt per share
—
—
—
1.11
1.09
0.96
3.8
Cash per share
—
0.9
0.3
1.26
0.89
0.77
2.87
Net current asset value per share
—
1.77
1.24
2.03
1.59
1.42
5.12
Tangible book value per share
—
1.56
1.09
0.77
0.4
0.35
0.93
Working capital per share
—
1.38
0.9
1.66
1.29
1.14
4.07
Book value per share
—
1.56
1.09
0.77
0.4
0.35
0.93
Nouvelles
Tilray Brands' Q3 Earnings on the Horizon: What's in The Offing?
Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year?
BTIG relève sa recommandation sur Apyx Medical en raison de la demande GLP-1
Apyx Medical Corporation (APYX) Q4 2025 Earnings Call Transcript
Le BPA de Apyx Medical a dépassé les attentes de 0,03$, le CA a surpassé les prévisions
Apyx Medical earnings beat by $0.03, revenue topped estimates
Quanterix Corporation (QTRX) Reports Q4 Loss, Beats Revenue Estimates
Apyx Medical reports 34% revenue growth in Q4 2025
Roth/MKM initie la couverture de l’action Apyx Medical avec une recommandation d’achat
Roth/MKM initiates coverage on Apyx Medical stock with Buy rating
InMode's Shares Are Too Cheap To Ignore: The Bottom May Be In (NASDAQ:INMD)
Apyx Medical lance sa console Apyx One en Corée du Sud